Nurse-centred care of HIV patients can be just as safe and effective as care delivered by doctors and has a number of specific health benefits, according to a new study led by the University of East Anglia (UEA) and the University ...
Aug 14, 2012
0
0
(HealthDay) -- For patients with type 2 diabetes (T2D), treatment with salsalate does not improve endothelial function as measured by flow-mediated, endothelium-dependent dilation (FMD), although it is associated with lower ...
Jun 12, 2012
0
0
(HealthDay)—Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among adults undergoing cancer chemotherapy.
Sep 2, 2015
0
14
(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with Philadelphia chromosome negative acute lymphoblastic leukemia (ALL).
Aug 10, 2012
0
0
(HealthDay)—Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft-tissue sarcomas, cancers that develop in areas such as the muscles, fat, blood vessels and tendons.
Oct 19, 2016
0
0
(HealthDay)—When given to pregnant women, a common treatment for ulcerative colitis may inadvertently lower their baby's ability to fight off infections at birth, new French research suggests.
Oct 3, 2014
0
0
South Africa's government plans to extend AIDS tests to the country's entire population and speed up antiretroviral treatment of those who test positive for the virus, the health minister said Wednesday.
Jul 23, 2014
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved the first device to treat dialysis-related amyloidosis (DRA), a complication of dialysis used to treat kidney failure.
Mar 6, 2015
0
7
(HealthDay)—For patients with irritable bowel syndrome (IBS), a positive diagnostic strategy is non-inferior to a strategy of exclusion for patients' health-related quality of life (HRQOL), according to a study published ...
Aug 9, 2013
0
0
(HealthDay)—Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).
Jul 3, 2014
0
0
